|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Post-synthesis phase and shape evolution of CsPbBr3 colloidal nanocrystals: The role of ligands显示文摘The surface chemistry of colloidal cesium lead bromide (CsPbBr3) nanocrystals is decisive in determining the stability and the final morphology of this class of materials,characterized by ionic structure and a high defect tolerance factor.Here,the high sensitivity of purified colloidal nanocubes of CsPbBr3 to diverse environmental condition (solvent dilution,ageing,ligands post synthetic treatment) in ambient atmosphere is investigated by means of a comprehensive morphological (electron microscopy),structural (θ/2θ X-ray diffraction (XRD) and grazing incidence wide angle scattering (GIWAXS)),and spectroscopic chemical (1H nuclear magnetic resonance (NMR),nuclear Overhauser effect spectroscopy (NOESY),absorption and emission spectroscopy) characterization.The aging and solvent dilution contribute to modify the nanocrystal morphology,due to a modification of the ligand dynamic.Moreover,we establish the ability of aliphatic carboxylic acids and aikyl amines ligands to induce,even in a post preparative process at room temperature,structural,morphological and spectroscopic variations.Upon post synthesis alkyl amine addition,in particular of oleyl amine and octyl amine,the highly green emitting CsPbBr3 nanocubes effectively tum into one-dimensional (1 D) thin tetragonal nanowires or lead halide deficient rhombohedral zero-dimensional (0D) Cs4PbBr6 structures with a complete loss of fluorescence.The addition of an alkyl carboxylic acid,as oleic and nonanoic acid,produces the transformation of nanocubes into still emitting orthorombic two-dimensional (2D) nanoplates.The acid/base equilibrium between the native and added ligands,the edsorbed/free ligands dynamic in solution and the ligand solubility in non-polar solvent contribute to render CsPbBr3 particularly sensitive to environmental and processing conditions and,therefore prone to undergo to structural,morphological and,hence spectroscopic,transformations. | Elisabetta Fanizza Francesca Cascella Davide Altamura Cinzia Giannini Annamaria Panniello Leonardo Triggiani Francesca Panzarea Nicoletta Depalo Roberto Grisorio Gian Paolo Suranna Angela Agostiano M.Lucia Curri Marinella Striccoli | 2019 | Nano Research2019，12，5： | 2 |
| 2 | n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion: A Prospective, Randomized Study显示文摘 | Savina Nodari Marco Triggiani Umberto Campia Alessandra Manerba Giuseppe Milesi Bruno M. Cesana Mihai Gheorghiade Livio Dei Cas | 2011 | Circulation2011，，10： | 2 |
| 3 | Differential modula- tion of mediator release from human basophils and mast cells by mizo- lastine 显示文摘 | Triggiani M Giannattasio G Balestrieri B | 2004 | Clin Exp Allergy2004，34，2： | 1 |
| 4 | Diffuse 3JI lung uptake in bronchiectasis:a potential pitfall in the follow-up of differentiated thyroid carcinoma显示文摘 | Triggiani V Moschetta M Giagulli VA | 2012 | Thyroid2012，22，12： | 1 |
| 5 | n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion:a prospective,randomized study显示文摘 | Nodari S Triggiani M Campia U | 2011 | Circulation2011，124，10： | 1 |
| 6 | Regularity of hyperbolic equations underL 2(0,T; L 2 (Γ))-Dirichlet boundary terms显示文摘 | I. Lasiecka R. Triggiani | 1983 | Applied Mathematics & Optimization1983，，1： | 1 |
| 7 | Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer : role of hormones, growth factors and specific receptors 显示文摘 | Guastamacchia E Resta F Triggiani V | 2004 | Curr Drug Immune Endoer Metabol Disord2004，4，1： | 1 |
| 8 | Differential modulation of mediator release from human basophils and mast cells by mizolastine显示文摘 | Triggiani M Giannattasio G Balestrieri B | 2004 | Clin Exp Allergy2004，34，2： | 1 |
| 9 | Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes 显示文摘 | Triggiani M Granata F Giannattasio G | 2005 | J Allergy Clin Immunol2005，116，5： | 1 |
| 10 | Differential modulation of mediator release from human basophils and mast cells by mizolastine显示文摘 | Triggiani M Giannattasio G Balestrieri B | 2004 | Clin Exp Allergy2004，34，： | 1 |
| 11 | Differential modulation of mediator release from human basophils and mast cells by mizolastine显示文摘 | Triggiani M Giannattasio G Balestrieri B | 2004 | Clin Exp Allergy2004，34，2： | 1 |
| 12 | Nonhomoge- neous boundary value problem for second-order hy- perbolic operators 显示文摘 | Lasiecka I Lions J L Triggiani R | 1986 | J Math Pures Appl1986，65，： | 1 |
| 13 | Insulin resistance in essential hypertension: a psychophysiological approach to the 'chicken and egg' question 显示文摘 | NAZZARO P TRIGGIANI R CIANCIO L | 2000 | Nutr Metab Cardiovasc Dis2000，10，5： | 1 |
| 14 | Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors 显示文摘 | Guastamacchia E Resta F Triggiani V | 2004 | Curt Drug Targets Immune Endocr Metabol Disord2004，4，1： | 1 |
| 15 | Inverse/observability Estimates for Second-order Hyperbolic Equations with Variable Systems显示文摘 | Lasiecka I Triggiani R Yao P F | | 0，，： | 1 |
| 16 | Microcalcifications and psammoma bodies in thyroid tumors显示文摘 | Triggiani V Guastamacchia E Licchelli B | 2008 | Thyroid2008，18，9： | 1 |
| 17 | A note on the lack of exact controllability for mild solutions in Banach spaces 显示文摘 | Triggiani R | 1977 | SIAM Journal on Control & Optimization1977，15，3： | 1 |
| 18 | Differential modulation of mediater release from human basophils and mast cells by mizolastine显示文摘 | Triggiani M Giannattasio G Batestrieri B | 2004 | Clin Exp Allergy2004，34，2： | 1 |
| 19 | Adva- ntages of delayed sternal closure in cardiac compromised adult patients显示文摘 | DONATELLI F TRIGGIANI M BENUSSI S | 1995 | J Card Surg1995，10，： | 1 |
| 20 | Thyroid disorders in chronic heart fail-ure: from prognostic set-up to therapeutic management显示文摘 | Triggiani V Iacoviello M | 2013 | En-docr Metab Immune Disord Drug Targets2013，13，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员